Mammoth Biosciences
Ria Shah is a Senior Research Associate at Mammoth Biosciences, specializing in CRISPR off-target, safety, and specificity since July 2021. Previously, Ria held the title of Research Associate, leading the NGS Core, and worked at SeqMatic from September 2020 to May 2021, where responsibilities included performing Next Generation Sequencing experiments, building NGS libraries, and managing Illumina sequencing platforms. Ria began a research career as a Research Assistant at the Ghetti Lab within the UC Davis Memory & Development Lab from October 2018 to March 2020. Ria earned a Bachelor of Science degree in Biochemistry and Molecular Biology from the University of California, Davis.
This person is not in the org chart
This person is not in any teams
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.